Artificial Intelligence with CBC based Morphometric Parameters aimed toward effective diagnostic practices for Dysplasia associated Hematological Malignancies
Source check: Source checked. Not independent scientific confirmation.
Finding: Machine-learning classification of CBC morphometric and cell-population features distinguished dysplasia-associated hematologic malignancy groups in a retrospective clinical sample. The result is limited to the study’s patient groups and does not establish prospective diagnostic performance.
Technology: Machine-learning classifiers assess dysplasia-associated hematologic malignancy from CBC morphometric features.
Publication: Preprint · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Machine-learning classifiers assess dysplasia-associated hematologic malignancy from CBC morphometric features.
- Test and result
- CBC morphometric and cell-population measurements were evaluated with machine-learning classifiers for dysplasia-associated hematologic malignancy groups.
- Limitation / still unknown
- The evidence is retrospective and limited to the reported patient groups; prospective workflow validation was not shown.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://assets-eu.researchsquare.com/files/rs-1349008/v1/da889f2c-9039-4610-b8c2-7cd4874ad4dd.pdf · https://api.crossref.org/works/10.21203/rs.3.rs-1349008/v1
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.